Consideration of Native Coronary Disease Progression in the Decision to Perform Hybrid Coronary Revascularization

Abstract

Get full access to this article

View all access options for this article.

References

McGinn

J.T.

Jr. , Usman

, Lapierre

, Pothula

V.R.

, Mesana

T.G.

, Ruel

Minimally invasive coronary artery bypass grafting: dual-center experience in 450 consecutive patients. Circulation. 2009; 120(Suppl 11): S78–S84.

Cutlip

D.E.

, Chhabra

A.G.

, Baim

D.S.

Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation. 2004; 110: 1226–1230.

Mauri

, Kereiakes

D.J.

, Yeh

R.W.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014; 371: 2155–2166.

Taniwaki

, Windecker

, Zaugg

The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study. Eur Heart J. 2015; 36: 2167–2176.

Farooq

, Serruys

P.W.

, Zhang

Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial. J Am Coll Cardiol. 2013; 62: 2360–2369.

Farkouh

, Domanski

, Sleeper

L.A.

Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012; 367: 2375–2384.

Une

, Kulik

, Voisine

, Le May

, Ruel

Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial. Circulation. 2013; 128(11 suppl 1): S213–S218.

Alderman

E.L.

, Kip

K.E.

, Whitlow

P.L.

Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2004; 44: 766–774.

Singh

R.N.

Progression of coronary atherosclerosis. Clues to pathogenesis from serial coronary arteriography. Br Heart J. 1984; 52: 451–461.

10.

Brower

R.W.

, Laird-Meeter

, Serruys

P.W.

, Meester

G.T.

, Hugenholtz

P.G.

Long term follow-up after coronary artery bypass graft surgery. Progression and regression of disease in native coronary circulation and bypass grafts. Br Heart J. 1983; 50: 42–47.

11.

Borges

J.C.

, Lopes

, Soares

P.R.

Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery. J Cardiothorac Surg. 2010; 5: 91.

12.

Chen

, Théroux

, Lespérance

, Shabani

, Thibault

, De Guise

Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. J Am Coll Cardiol. 1996; 28: 1493–1499.

13.

Lichtlen

P.R.

, Nikutta

, Jost

, Deckers

, Wiese

, Rafflenbeul

Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Relation to clinical events and risk factors. The INTACT Study Group. Circulation. 1992; 86: 828–838.

14.

Waters

, Craven

T.E.

, Lesperance

Prognostic significance of progression of coronary atherosclerosis. Circulation. 1993; 87: 1067–1075.

15.

Hayward

P.A.

, Zhu

Y.Y.

, Nguyen

T.T.

, Hare

D.L.

, Buxton

B.F.

Should all moderate coronary lesions be grafted during primary coronary bypass surgery? An analysis of progression of native vessel disease during a randomized trial of conduits. J Thorac Cardiovasc Surg. 2013; 145: 140–148.

16.

Hwang

M.H.

, Meadows

W.R.

, Palac

R.T.

Progression of native coronary artery disease at 10 years: Insights from a randomized study of medical versus surgical therapy for angina. J Am Coll Cardiol. 1990; 16: 1066–1070.

17.

Alderman

E.L.

Angiographic correlates of graft patency and relationship to clinical outcomes. Ann Thorac Surg. 1996; 62: S22–S25.

18.

Dimitrova

K.R.

, Hoffman

D.M.

, Geller

C.M.

, Dincheva

, Ko

, Tranbaugh

R.F.

Arterial grafts protect the native coronary vessels from atherosclerotic disease progression. Ann Thorac Surg. 2012; 94: 475–481.

19.

Alderman

E.L.

, Corley

S.D.

, Fisher

L.D.

Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol. 1993; 22: 1141–1154.

20.

Chatzizisis

Y.S.

, Giannoglou

G.D.

, Parcharidis

G.E.

, Louridas

G.E.

Is left coronary system more susceptible to atherosclerosis than right? A pathophysiological insight. Int J Cardiol. 2007; 116: 7–13.

21.

Glaser

, Selzer

, Faxon

D.P.

Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation. 2005; 111: 143–149.

22.

Zellweger

M.J.

, Kaiser

, Jeger

Coronary artery disease progression late after successful stent implantation. J Am Coll Cardiol. 2012; 59: 793–799.

23.

Rupprecht

H.J.

, Hamm

, Ischinger

, Dietz

, Reimers

, Meyer

Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI Trial). GABI Study Group. Eur Heart J. 1996; 17: 1192–1198.

24.

Tatoulis

, Buxton

B.F.

, Fuller

J.A.

Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg. 2004; 77: 93–101.

25.

Habib

R.H.

, Dimitrova

K.R.

, Badour

S.A.

CABG versus PCI: Greater benefit in long-term outcomes with multiple arterial bypass grafting. J Am Coll Cardiol. 2015; 66: 1417–1427.

26.

Buxton

B.F.

, Shi

W.Y.

, Tatoulis

, Fuller

J.A.

, Rosalion

, Hayward

P.A.

Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival. J Thorac Cardiovasc Surg. 2014; 148: 1238–1243.

27.

Puskas

J.D.

, Sadiq

, Vassiliades

T.A.

, Kilgo

P.D.

, Lattouf

O.M.

Bilateral internal thoracic artery grafting is associated with significantly improved long-term survival, even among diabetic patients. Ann Thorac Surg. 2012; 94: 710–715.

28.

Kurlansky

, Traad

, Dorman

, Galbut

, Zucker

, Ebra

Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups. Ann Thorac Surg. 2010; 90: 101–108.

29.

Lytle

, Blackstone

E.H.

, Sabik

J.F.

, Houghtaling

, Loop

F.D.

, Cosgrove

D.M.

The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg. 2004; 78: 2005–2012.

30.

Locker

, Schaff

H.V.

, Daly

R.C.

Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with percutaneous coronary interventions. J Thorac Cardiovasc Surg. 2016; 152: 369–379.

31.

Hillis

L.D.

, Smith

P.K.

, Anderson

J.L.

2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124: e652–e735.

32.

Gąsior

, Zembala

M.O.

, Tajstra

Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv. 2014; 7: 1277–1283.

33.

Harskamp

R.E.

, Bagai

, Halkos

M.E.

Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patients. Am Heart J 2014; 167: 585–592.

34.

Harskamp

R.E.

, Walker

P.F.

, Alexander

J.H.

Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. Am Heart J. 2014; 168: 471–478.

35.

Leacche

, Zhao

D.X.

, Umakanthan

, Byrne

J.G.

Do hybrid procedures have proven clinical utility and are they the wave of the future? Hybrid procedures have no proven clinical utility and are not the wave of the future. Circulation. 2012; 125: 2504–2510.

36.

Shannon

, Colombo

, Alfieri

Do hybrid procedures have proven clinical utility and are they the wave of the future? Hybrid procedures have proven clinical utility and are the wave of the future. Circulation. 2012; 125: 2492–2503.

37.

Morice

M.C.

, Serruys

P.W.

, Kappetein

A.P.

Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial. Circulation. 2014; 129: 2388–2394.

38.

Tatoulis

, Buxton

B.F.

, Fuller

J.A.

Long-term patency of 1108 radial arterial-coronary angiograms over 10 years. Ann Thorac Surg. 2009; 88: 23–29.

39.

Desai

, Naylor

C.D.

, Kiss

Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial. Circulation. 2007; 115: 684–691.

40.

Deb

, Cohen

E.A.

, Singh

S.K.

, Une

, Laupacis

, Fremes

S.E.

Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012; 60: 28–35.